540 related articles for article (PubMed ID: 16430785)
1. In vitro and in vivo MMP gene expression localisation by In Situ-RT-PCR in cell culture and paraffin embedded human breast cancer cell line xenografts.
Haupt LM; Thompson EW; Trezise AE; Irving RE; Irving MG; Griffiths LR
BMC Cancer; 2006 Jan; 6():18. PubMed ID: 16430785
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase localisation by in situ-RT-PCR in archival human breast biopsy material.
Haupt LM; Irving RE; Weinstein SR; Irving MG; Griffiths LR
Mol Cell Probes; 2008 Apr; 22(2):83-9. PubMed ID: 17669621
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of matrix metalloproteinases (MMPs) in breast cancer xenografts: a major induction of stromal MMP-13.
Lafleur MA; Drew AF; de Sousa EL; Blick T; Bills M; Walker EC; Williams ED; Waltham M; Thompson EW
Int J Cancer; 2005 Apr; 114(4):544-54. PubMed ID: 15551360
[TBL] [Abstract][Full Text] [Related]
4. MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells.
Pulyaeva H; Bueno J; Polette M; Birembaut P; Sato H; Seiki M; Thompson EW
Clin Exp Metastasis; 1997 Mar; 15(2):111-20. PubMed ID: 9062387
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of MMP-11 (stromelysin-3) expression in mouse fibroblasts by cytokines, collagen and co-culture with human breast cancer cell lines.
Selvey S; Haupt LM; Thompson EW; Matthaei KI; Irving MG; Griffiths LR
BMC Cancer; 2004 Jul; 4():40. PubMed ID: 15272933
[TBL] [Abstract][Full Text] [Related]
6. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
7. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
Jones JL; Shaw JA; Pringle JH; Walker RA
J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
[TBL] [Abstract][Full Text] [Related]
8. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma.
Gilles C; Polette M; Seiki M; Birembaut P; Thompson EW
Lab Invest; 1997 May; 76(5):651-60. PubMed ID: 9166284
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
10. Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells.
Jiang WG; Davies G; Martin TA; Parr C; Watkins G; Mason MD; Mansel RE
Int J Mol Med; 2006 Apr; 17(4):583-90. PubMed ID: 16525713
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis.
Li DQ; Hou YF; Wu J; Chen Y; Lu JS; Di GH; Ou ZL; Shen ZZ; Ding J; Shao ZM
Eur J Cancer; 2006 Dec; 42(18):3274-86. PubMed ID: 16979889
[TBL] [Abstract][Full Text] [Related]
12. Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro.
Loo WT; Chen JP; Chow LW; Chou JW
Biomed Pharmacother; 2007 Oct; 61(9):601-5. PubMed ID: 17913446
[TBL] [Abstract][Full Text] [Related]
13. Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.
Cardillo MR; Di Silverio F; Gentile V
Anticancer Res; 2006; 26(2A):973-82. PubMed ID: 16619495
[TBL] [Abstract][Full Text] [Related]
14. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
[TBL] [Abstract][Full Text] [Related]
15. Expression of membrane-type 1, 2, and 3 matrix metalloproteinases messenger RNA in ovarian carcinoma cells in serous effusions.
Davidson B; Goldberg I; Berner A; Nesland JM; Givant-Horwitz V; Bryne M; Risberg B; Kristensen GB; Tropé CG; Kopolovic J; Reich R
Am J Clin Pathol; 2001 Apr; 115(4):517-24. PubMed ID: 11293899
[TBL] [Abstract][Full Text] [Related]
16. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.
Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI
BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-1 is a crucial bone metastasis factor in a human breast cancer-derived highly invasive cell line.
Okuyama N; Matsumine A; Kosugi R; Wakabayashi H; Uchida A
Oncol Rep; 2008 Dec; 20(6):1497-504. PubMed ID: 19020733
[TBL] [Abstract][Full Text] [Related]
18. Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases.
Hagemann T; Robinson SC; Schulz M; Trümper L; Balkwill FR; Binder C
Carcinogenesis; 2004 Aug; 25(8):1543-9. PubMed ID: 15044327
[TBL] [Abstract][Full Text] [Related]
19. Cell density-dependent regulation of matrix metalloproteinase and TIMP expression in differently tumorigenic breast cancer cell lines.
Bachmeier BE; Albini A; Vené R; Benelli R; Noonan D; Weigert C; Weiler C; Lichtinghagen R; Jochum M; Nerlich AG
Exp Cell Res; 2005 Apr; 305(1):83-98. PubMed ID: 15777790
[TBL] [Abstract][Full Text] [Related]
20. Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro.
Balduyck M; Zerimech F; Gouyer V; Lemaire R; Hemon B; Grard G; Thiebaut C; Lemaire V; Dacquembronne E; Duhem T; Lebrun A; Dejonghe MJ; Huet G
Clin Exp Metastasis; 2000; 18(2):171-8. PubMed ID: 11235993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
